AHR and Hypertension: On the other hand, maternal DMB therapy protects progeny against hypertension programmed by TCDD, which is related to alterations of gut microbiota composition, mediation of TMA-TMAO metabolic pathway, regulation of SCFA and their receptors, and restoration of the RAS and AHR signaling pathway.